Dr Jay Shukla
Dr Jay Shukla
Details
Role
Technology Transfer Officer
Group
Innovation
Top Publications
- Finkelstein, DI, Shukla, JJ, Cherny, RA, Billings, JL, Saleh, E, Stefanova, N, Barnham, KJ, Adlard, PA. The Compound ATH434 Prevents Alpha-Synuclein Toxicity in a Murine Model of Multiple System Atrophy. Journal of Parkinson's Disease 12(1) : 105 -115 2022 view publication
- Shukla, JJ, Stefanova, N, Bush, AI, McColl, G, Finkelstein, DI, McAllum, EJ. Therapeutic potential of iron modulating drugs in a mouse model of multiple system atrophy. Neurobiology of Disease 159: 105509 2021 view publication
- Rao, SS, Lago, L, Volitakis, I, Shukla, JJ, McColl, G, Finkelstein, DI, Adlard, PA. Correction to: Deferiprone Treatment in Aged Transgenic Tau Mice Improves Y-Maze Performance and Alters Tau Pathology. Neurotherapeutics 18(4) : 2759 -2761 2021 view publication
- Rao, SS, Lago, L, Volitakis, I, Shukla, JJ, McColl, G, Finkelstein, DI, Adlard, PA. Deferiprone Treatment in Aged Transgenic Tau Mice Improves Y-Maze Performance and Alters Tau Pathology. Neurotherapeutics 18(2) : 1081 -1094 2021 view publication
Share //
